Healthcare Industry

• Nº 3 in health expenditures worldwide: 10.4% of GDP (total 2008: EUR 253 billion, Statutory Health Insurance system 2008: EUR 160.8 billion
• Revenues (2008): Pharmaceuticals EUR 31.8 billion, Medical devices EUR 17.76 billion, Biopharmaceuticals EUR 1.1 billion
• export ratio (2008): Medical devices 65%, Pharmaceuticals 56%
• 4.4 million employees in the healthcare sector
• 21,500 pharmacies, 3,326 hospitals and prevention and rehab institutions, 809 HMOs, 34 university hospitals, 11,000 medical device companies, 1,031 pharmaceutical companies, and 500 biotech companies(2007)

MARKET - Germany's healthcare industry ranks as Europe's largest. From 2000 to 2007, health expenditures rose from EUR 212.5 billion to EUR 252.8 billion, corresponding to a total growth of 19 percent – 2.7 percent higher than the increase in GDP. Germany has 82 million inhabitants, and the country’s ageing society is a growth driver for the healthcare industry.

INDUSTRIAL INFRASTRUCTURE - Nearly every German citizen benefits from health insurance. About 89 percent are covered by one of the public insurance providers, while about 9 percent choose a private system. The challenges of an ageing society are met by players in fields such as generics and health management - these sectors are also fostered by the health reforms recently passed by the German government.

PERSONNEL - Germany's healthcare industry employs 4.4 million highly skilled people, including doctors, engineers, chemists, physicists, mathematicians, and pharmacists. In addition, 116,237 health science and medical students, and 78,001 graduates in biology, chemistry, and medical engineering are ready to work for you.

R&D - Maintaining Germany's high level of healthcare quality, while at the same time keeping the healthcare system affordable, is a declared goal of Germany's health policy. Innovative products and technologies "Made in Germany" contribute to this goal.

INCENTIVES - The government's "High-Tech Strategy" supports innovation in the sectors of biotechnology, pharmaceuticals, and medical devices. From 2006 to 2009, funds totaling EUR 1.23 billion will be made available.

PHYSICAL INFRASTRUCTURE - We offer an extensive and comprehensive logistics infrastructure that integrates state-of-the-art transportation networks with the most modern telematics, IT, and telecommunications systems.

STABLE INVESTMENT ENVIRONMENT - Social, economic, and political stability provide a solid base for your corporate projects. Our judiciary and civil services are highly professional. Contractual agreements are secure, and intellectual property is strictly protected in Germany.

• Healthways, Inc.